Procysbi 25mg / 75mg gastro-resistant hard capsules
*Company:
Chiesi LimitedStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Educational materials 'FOR HEALTHCARE PROFESSIONALS' (HCPs) are additional risk minimisation measures that are intended to promote the safe and effective use of the medicinal product.
(Click to Download) PROCYSBI - AE Follow Up Form for Ehlers-Danlos-like Syndrome
Risk Minimisation Materials
(Click to Download) PROCYSBI - Safety Checklist for Prescribing Physicians
Risk Minimisation Materials
(Click to Download) PROCYSBI - AE Follow Up Form for Encephalopathy
Risk Minimisation Materials
(Click to Download) PROCYSBI - AE Follow Up Form for Fibrosing Colonopathy
Risk Minimisation Materials
(Click to Download) PROCYSBI - AE Follow Up Form for Pregnancy
Risk Minimisation Materials
Chiesi Limited
Address:
Chiesi Limited, 333 Styal Road, Manchester, M22 5LGMedical Information E-mail:
Medinfo.uk@chiesi.comTelephone:
+44 (0) 161 488 5555 , 1800 817 459Website:
https://www.chiesi.uk.com https://www.chiesimedical.co.ukMedical Information Direct Line:
+44 (0)1748 827 271Stock Availability:
CustomerServices.UK@chiesi.com